Journal article
Comparison of intravenous dosing regimens for maintaining steady-state procainamide levels during programmed ventricular stimulation
The American journal of cardiology, v 70(11), pp 1087-1088
1992
PMID: 1384303
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Intravenous procainamide hydrochloride has prognostic value for drug efficacy in electrophysiologic testing in patients with sustained ventricular tachycardia
1,2 and is often used as an initial screen for drug therapy in these patients. To evaluate the effects of varying intravenous procainamide dosing regimens on providing stable plasma concentrations of the drug in the clinical electrophysiology laboratory, we compared procainamide dosing and maintenance infusions determined by population kinetics
3 with those of a standard fixed dose and maintenance infusion.
2
Metrics
Details
- Title
- Comparison of intravenous dosing regimens for maintaining steady-state procainamide levels during programmed ventricular stimulation
- Creators
- Robert T. Brautigam - Hahnemann University HospitalMelinda Schuster - Hahnemann University HospitalR.Stephen Porter - Hahnemann University HospitalCharles Nydegger - Hahnemann University HospitalSteven P. Kutalek - Hahnemann University Hospital
- Publication Details
- The American journal of cardiology, v 70(11), pp 1087-1088
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:A1992JT34700023
- Scopus ID
- 2-s2.0-0026656148
- Other Identifier
- 991019340429504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Cardiac & Cardiovascular Systems